232 related articles for article (PubMed ID: 8626511)
1. The differential effects of the Gly-60 to Ala mutation on the interaction of H-Ras p21 with different downstream targets.
Hwang MC; Sung YJ; Hwang YW
J Biol Chem; 1996 Apr; 271(14):8196-202. PubMed ID: 8626511
[TBL] [Abstract][Full Text] [Related]
2. Peptides containing a consensus Ras binding sequence from Raf-1 and theGTPase activating protein NF1 inhibit Ras function.
Clark GJ; Drugan JK; Terrell RS; Bradham C; Der CJ; Bell RM; Campbell S
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1577-81. PubMed ID: 8643674
[TBL] [Abstract][Full Text] [Related]
3. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.
Moodie SA; Paris M; Villafranca E; Kirshmeier P; Willumsen BM; Wolfman A
Oncogene; 1995 Aug; 11(3):447-54. PubMed ID: 7630628
[TBL] [Abstract][Full Text] [Related]
4. Mutagenesis of the H-ras p21 at glycine-60 residue disrupts GTP-induced conformational change.
Sung YJ; Carter M; Zhong JM; Hwang YW
Biochemistry; 1995 Mar; 34(10):3470-7. PubMed ID: 7880841
[TBL] [Abstract][Full Text] [Related]
5. ralGDS family members interact with the effector loop of ras p21.
Kikuchi A; Demo SD; Ye ZH; Chen YW; Williams LT
Mol Cell Biol; 1994 Nov; 14(11):7483-91. PubMed ID: 7935463
[TBL] [Abstract][Full Text] [Related]
6. Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap.
Spaargaren M; Bischoff JR
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12609-13. PubMed ID: 7809086
[TBL] [Abstract][Full Text] [Related]
7. The dominant negative effects of H-Ras harboring a Gly to Ala mutation at position 60.
Sung YJ; Hwang MC; Hwang YW
J Biol Chem; 1996 Nov; 271(48):30537-43. PubMed ID: 8940023
[TBL] [Abstract][Full Text] [Related]
8. Guanine-nucleotide binding activity, interaction with GTPase-activating protein and solution conformation of the human c-Ha-Ras protein catalytic domain are retained upon deletion of C-terminal 18 amino acid residues.
Fujita-Yoshigaki J; Ito Y; Yamasaki K; Muto Y; Miyazawa T; Nishimura S; Yokoyama S
J Protein Chem; 1992 Dec; 11(6):731-9. PubMed ID: 1466766
[TBL] [Abstract][Full Text] [Related]
9. Novel, activated RAS mutations alter protein-protein interactions.
Dalley BK; Cannon JF
Oncogene; 1996 Sep; 13(6):1209-20. PubMed ID: 8808695
[TBL] [Abstract][Full Text] [Related]
10. Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator.
Hofer F; Fields S; Schneider C; Martin GS
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11089-93. PubMed ID: 7972015
[TBL] [Abstract][Full Text] [Related]
11. Regulation of interaction of ras p21 with RalGDS and Raf-1 by cyclic AMP-dependent protein kinase.
Kikuchi A; Williams LT
J Biol Chem; 1996 Jan; 271(1):588-94. PubMed ID: 8550624
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of the complex between p21ras and the Ras-binding domain of the human Raf-1 protein kinase.
Herrmann C; Martin GA; Wittinghofer A
J Biol Chem; 1995 Feb; 270(7):2901-5. PubMed ID: 7852367
[TBL] [Abstract][Full Text] [Related]
13. A conserved region of c-Ha-Ras is required for efficient GTPase stimulation by GTPase activating protein but not neurofibromin.
Yoder-Hill J; Golubic M; Stacey DW
J Biol Chem; 1995 Nov; 270(46):27615-21. PubMed ID: 7499225
[TBL] [Abstract][Full Text] [Related]
14. Ras-catalyzed hydrolysis of GTP: a new perspective from model studies.
Maegley KA; Admiraal SJ; Herschlag D
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8160-6. PubMed ID: 8710841
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional structure of p21H-ras and its implications.
Wittinghofer F
Semin Cancer Biol; 1992 Aug; 3(4):189-98. PubMed ID: 1421163
[TBL] [Abstract][Full Text] [Related]
16. TC21 causes transformation by Raf-independent signaling pathways.
Graham SM; Vojtek AB; Huff SY; Cox AD; Clark GJ; Cooper JA; Der CJ
Mol Cell Biol; 1996 Nov; 16(11):6132-40. PubMed ID: 8887643
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Ras/Raf interaction by anti-oncogenic mutants of neurofibromin, the neurofibromatosis type 1 (NF1) gene product, in cell-free systems.
Mori S; Satoh T; Koide H; Nakafuku M; Villafranca E; Kaziro Y
J Biol Chem; 1995 Dec; 270(48):28834-8. PubMed ID: 7499408
[TBL] [Abstract][Full Text] [Related]
18. Regional polysterism in the GTP-bound form of the human c-Ha-Ras protein.
Ito Y; Yamasaki K; Iwahara J; Terada T; Kamiya A; Shirouzu M; Muto Y; Kawai G; Yokoyama S; Laue ED; Wälchli M; Shibata T; Nishimura S; Miyazawa T
Biochemistry; 1997 Jul; 36(30):9109-19. PubMed ID: 9230043
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional structure of the Ras-interacting domain of RalGDS.
Huang L; Weng X; Hofer F; Martin GS; Kim SH
Nat Struct Biol; 1997 Aug; 4(8):609-15. PubMed ID: 9253406
[TBL] [Abstract][Full Text] [Related]
20. Post-translational modifications of Ras and Ral are important for the action of Ral GDP dissociation stimulator.
Hinoi T; Kishida S; Koyama S; Ikeda M; Matsuura Y; Kikuchi A
J Biol Chem; 1996 Aug; 271(33):19710-6. PubMed ID: 8702675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
